Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-29

Clinical Trial Update: Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing haplo-identical hematopoietic stem cell transplantation to chemotherapy for adult acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Haploidentical hematopoietic stem cell transplantation (haploidentical hematopoietic stem cell transplantation)

Snippet

Sponsor: Peking University | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED